Darrel P Cohen, MD, PhD
Viracta Therapeutics
2
0
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Bilal Omer, MD
Baylor College of Medicine
Shared therapeutic areas:
Lizhi Niu, PhD
Fuda Cancer Hospital
Shared therapeutic areas:
Han-Kuei Wu, Ph.D.
China Medical University, China
Shared therapeutic areas:
Xiaozhong Chen, MD
Zhejiang Cancer Hospital
Shared therapeutic areas:
Kun San Chao, M.D.
China Medical University, China
Shared therapeutic areas:
Yifan Zhai, MD, PhD
Ascentage Pharma Group Inc.
Shared therapeutic areas:
Chia-Hao Chang, M.M.S.
China Medical University, China
Shared therapeutic areas:
Nieto Luis, Master
Site Coordinator of United Medical Group located in Miami
Shared therapeutic areas:
Jennifer Johnson, MD, PhD
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Shared therapeutic areas:
Weijun Wei, Ph.D. & M.D.
Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Nanatinostat Plus Valganciclovir in Advanced EBV+ Solid Tumors and in Combination With Pembrolizumab in EBV+ RM-NPC
An Open-Label Phase 2 Trial of Nanatinostat Plus Valganciclovir in Patients With EBV+ Relapsed/Refractory Lymphomas
All 2 trials loaded